EV/EBITDA
-2.84
+0.17+5.65%
Wed, 04 Dec 2024 00:54:09 GMT
Summary:
C4 Therapeutics EV/EBITDA is currently -2.84, with a rise of +0.17 (+5.65%) during the most recent trading day. Over the past year, it has dropped by -2.65 (-1394.74%). CCCC EV/EBITDA is now -14100.00% below its all-time high of -0.02.CCCC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +5.7% |
| 1 m1 month | +28.3% |
| 3 m3 months | +29.2% |
| 6 m6 months | +10.7% |
| ytdytd | -26.2% |
| 1 y1 year | -1394.7% |
| 5 y5 years | - |
CCCC EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -2.82 | -0.7% | -4.34 | +34.6% |
| 3 m | 3 months | -2.82 | -0.7% | -4.83 | +41.2% |
| 6 m | 6 months | -2.57 | -10.5% | -4.98 | +43.0% |
| 1 y | 1 year | -0.02 | <-9999.0% | -5.46 | +48.0% |
| 3 y | 3 years | -0.02 | <-9999.0% | -19.75 | +85.6% |
| 5 y | 5 years | -0.02 | <-9999.0% | -30.45 | +90.7% |
| alltime | all time | -0.02 | <-9999.0% | -30.45 | +90.7% |
C4 Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -2.84(+26.2%) |
| 2023 | -2.25(-19.4%) |
| Date | Value |
|---|---|
| 2022 | -2.79(-85.4%) |
| 2021 | -19.12(-3.3%) |
| 2020 | -19.77 |
FAQ
- What is C4 Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for C4 Therapeutics?
- What is CCCC EV/EBITDA year-to-date change?
- What is C4 Therapeutics EV/EBITDA year-on-year change?
What is C4 Therapeutics EV/EBITDA?
The current EV/EBITDA of CCCC is -2.84
What is the all time high EV/EBITDA for C4 Therapeutics?
C4 Therapeutics all-time high EV/EBITDA is -0.02
What is CCCC EV/EBITDA year-to-date change?
C4 Therapeutics EV/EBITDA has changed by -0.59 (-26.22%) since the beginning of the year
What is C4 Therapeutics EV/EBITDA year-on-year change?
Over the past year, CCCC EV/EBITDA has changed by -2.65 (-1394.74%)